Jingping Yun

18PUBLICATIONS
81CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 09, 2026
Spatiotemporal mapping of tertiary lymphoid structure heterogeneity shapes immune niches and clinical outcomes in intrahepatic cholangiocarcinoma.

|Sep 02, 2026
p38β-mediated BiP phosphorylation drives stemness and chemoresistance by suppressing UPR activation in hepatocellular carcinoma.

|Mar 12, 2026
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.

Jiawei Lv, Dan-Xue Zheng, Jin-Hui Liang

|Nov 11, 2025
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.

Martina Mang Leng Lei, Carmen Oi Ning Leung, Rainbow Wing Hei Leung

|Jul 27, 2025
SNORA58 Facilitates Radioresistance via Suppressing JNK1-Mediated Ferroptosis in Esophageal Squamous Cell Carcinoma.

Yinli Zheng, Fangyi Liu, Yuhua Huang

|Apr 10, 2025
Glycogen stores mediated by the p53-GYS1 feedback circuit engenders platinum resistance in ovarian clear cell carcinoma.

Hao-Yu Liang, Rong-Zhen Luo, Ru Deng

Pageof 3

Frequent Collaborators

7 joint publications

Stephanie Ma

5 joint publications

Man Tong

5 joint publications

Terence Kin-Wah Lee

4 joint publications

Tin-Lok Wong